Introduction: Emerging evidences have underscored the positive impact of biologics on asthmatic patients. However, there is a pressing need to verify their therapeutic efficacy in children and adolesc

Figshare2024-12-21 更新20

Predictors of outcome in patients treated with Rituximab.

临床疗效预测

生物制剂疗效评估

Predictors of outcome in patients treated with Rituximab.

Figshare2017-03-03 更新20

Baseline characteristics and laboratory findings of patients starting their first TNF-α inhibitor according to whether they subsequently switched or not.

风湿免疫治疗

生物制剂疗效评估

TNF, tumor necrosis factor; BMI, body mass index; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; AST, aspartate aminotransfer

NIAID Data Ecosystem30

Real-world evaluation of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa: A nationwide retrospective cohort study on behalf of the HS-SIDeMaST task force - Supplementary Materials

化脓性汗腺炎治疗

生物制剂疗效评估

Supplementary material Supplementary Material 1: Statistical methods Supplementary Material 2 - Table 1: Data stratified according to bimekizumab dose regimen Supplementary Material 3 - Table 2: Dat

Mendeley Data20

Data for: Biologic Agents Reduce a Narrow C-2 Pedicle in Patients with Rheumatoid Arthritis

资源简介：

相关数据集